Corheart 6 LVAS Study
Prospective Multi-Center Single-Arm Study for Evaluating the Corheart 6 Left Ventricular Assist System
Shenzhen Core Medical Technology CO.,LTD.
53 participants
May 14, 2024
INTERVENTIONAL
Conditions
Summary
The primary objective of this study is to evaluate the safety and effectiveness of the Corheart 6 LVAS when used for the treatment of advanced left ventricular heart failure in a European population at 6 months post-implantation. The secondary objective is to assess the long-term safety and effectiveness of Corheart 6 LVAS treatment.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Implantation of left ventricular assist device for mechanical circulatory support
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05876000